Filing Details

Accession Number:
0000899243-22-020094
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-31 10:16:50
Reporting Period:
2022-05-27
Accepted Time:
2022-05-31 10:16:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1750149 Inhibikase Therapeutics Inc. IKT Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827621 H. Milton Werner 3350 Riverwood Parkway Se, Suite 1900
Atlanta GA 30339
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-27 5,000 $0.98 5,330,433 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct